Sofosbuvir/velpatasvir/voxilaprevir - Gilead Sciences
At a glance
- Drug Originator Gilead Sciences
- Drug Class Antivirals; Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors; Hepatitis C virus NS3 protein inhibitors; Virus replication inhibitors
- USA Patent Applicants GILEAD SCIENCES INC
- USA Patents 38
- NDAs 1
- International Patents 617
Table of Contents

Disclaimer